Eisai Co., Ltd. completed a major renovation of its Tsukuba Research Laboratories in Ibaraki, Japan, as part of strategic investment to execute its medium-term business plan, “EWAY Future & Beyond.” Eisai implements research and development activities under the DHBL (Deep Human Biology Learning) drug discovery and development system in an effort to create new drugs based on innovative and efficient next-generation drug discovery concepts. According to the company, Tsukuba R...